ARTICLE | Emerging Company Profile
Karius: Blood will tell
Karius’ blood test diagnoses blood, deep tissue infections using cell-free DNA
October 26, 2018 10:59 PM UTC
Karius Inc. is diagnosing both blood-borne and deep-seated infections with its Karius Test, which sequences cell-free microbial DNA in blood samples and cuts the run time required in traditional assays.
The company spun out of Stanford University in 2014 and was co-founded by CEO Mickey Kertesz, CSO Tim Blauwkamp and Stephen Quake, a professor of bioengineering and applied physics at Stanford who serves on Karius’ scientific advisory board. ...